FEMY SCHEDULE 13G/A: SEC filing

Jorey Chernett

Filed with the SEC on · accession 0000921895-26-003188

FEMY filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -10.5% by the first close after the filing.

Summary of the filing

Jorey Chernett filed an Amendment No. 2 to a Schedule 13G indicating that as of September 30, 2026, he no longer beneficially owns any shares of Femasys Inc. common stock, constituting an exit filing.

Key details

Shares beneficially owned after exit$0
IssuerFemasys Inc
Reporting person (former shareholder)Jorey Chernett

How FEMY stock reacted

Close before

$1.43

Nov 13, 2026

First close after

-10.49%

$1.28

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for FEMY, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FEMY?

Click here

Frequently asked questions

What did FEMY file with the SEC on Nov 16, 2026?

FEMY filed a SCHEDULE 13G/A (SEC filing). Jorey Chernett filed an Amendment No. 2 to a Schedule 13G indicating that as of September 30, 2026, he no longer beneficially owns any shares of Femasys Inc. common stock, constituting an exit filing.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did FEMY stock react to this filing?

FEMY closed at $1.43 before the filing and $1.28 on Nov 16, 2026 (-10.49%).

Other FEMY SEC filings

Get alerts when FEMY files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days